Approval published for the first of a new type of medicine that may slow the development of kidney disease

  • 03 Feb 2022

The National Institute for Health and Social Care Excellence (NICE) have confirmed approval for a medicine called Dapagliflozin for use in some people who have Chronic Kidney Disease (CKD).